» Articles » PMID: 28534223

Immunoglobulin M Gene Association with Autoantibody Reactivity and Type 1 Diabetes

Overview
Journal Immunogenetics
Date 2017 May 24
PMID 28534223
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Several lines of evidence show that autoimmune responses evolving in type 1 diabetes (T1D) patients include the generation of multi-reactive autoantibody (AutoAb) repertoires, but their role in T1D pathogenesis remains elusive. We tested the hypothesis that variants at the immunoglobulin heavy chain (IGH) locus are genetic determinants of AutoAbs against pancreatic antigens and contribute to T1D susceptibility. With this aim, two independent study designs were used: a case-control study and a family-based cohort comprising a total of 240 T1D patients, 172 first-degree relatives (mother and/or father), and 130 unrelated healthy controls living in Portugal. We found that three SNPs in the IGH locus show suggestive association with T1D with the highest nominal association at rs1950942 (in the IGHM-IGHJ gene region) in both the case-control study (P = 9.35E-03) and the family-based cohort (P = 3.08E-03). These SNPs were also associated with IgG AutoAbs against pancreatic antigens and with AutoAb multi-reactivity in T1D patients. Notably, we found that the SNP with the highest association with T1D susceptibility and IgG autoantibody reactivity (rs1950942) was also associated with anti-GAD IgM reactivity in T1D patients (P = 5.98E-03) and in non-affected parents (P = 4.17E-03). This finding implies that IGH association with autoreactive IgM is detectable irrespective of disease status.These results suggest that genetic variants at the IgM gene region of the IGH locus contribute to antibody autoreactivity and are associated with T1D. We propose that the control of autoantibody generation by IGH polymorphisms is a component of the complex architecture of T1D genetic susceptibility.

Citing Articles

Serum APOC1 levels are decreased in young autoantibody positive children who rapidly progress to type 1 diabetes.

Hirvonen M, Lietzen N, Moulder R, Bhosale S, Koskenniemi J, Vaha-Makila M Sci Rep. 2023; 13(1):15941.

PMID: 37743383 PMC: 10518308. DOI: 10.1038/s41598-023-43039-4.


Exploring Computational Data Amplification and Imputation for the Discovery of Type 1 Diabetes (T1D) Biomarkers from Limited Human Datasets.

Alcazar O, Ogihara M, Ren G, Buchwald P, Abdulreda M Biomolecules. 2022; 12(10).

PMID: 36291653 PMC: 9599756. DOI: 10.3390/biom12101444.


Screening differentially expressed genes between endometriosis and ovarian cancer to find new biomarkers for endometriosis.

Lu Z, Gao Y Ann Med. 2021; 53(1):1377-1389.

PMID: 34409913 PMC: 8381947. DOI: 10.1080/07853890.2021.1966087.

References
1.
Corte-Real J, Duarte N, Tavares L, Penha-Goncalves C . Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes. Diabetologia. 2012; 55(6):1761-72. DOI: 10.1007/s00125-012-2498-0. View

2.
Plagnol V, Howson J, Smyth D, Walker N, Hafler J, Wallace C . Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 2011; 7(8):e1002216. PMC: 3150451. DOI: 10.1371/journal.pgen.1002216. View

3.
Ziegler A, Hummel M, Schenker M, Bonifacio E . Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 1999; 48(3):460-8. DOI: 10.2337/diabetes.48.3.460. View

4.
Elliott C, Lindner M, Arthur A, Brennan K, Jarius S, Hussey J . Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain. 2012; 135(Pt 6):1819-33. PMC: 3359756. DOI: 10.1093/brain/aws105. View

5.
Silva D, Daley S, Hogan J, Lee S, Teh C, Hu D . Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes. 2011; 60(8):2102-11. PMC: 3142068. DOI: 10.2337/db10-1344. View